Abbonarsi

Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: Implications for clinical practice - 28/08/11

Doi : 10.1067/mhj.2003.95 
Oscar C. Marroquin, MDa, Richard Holubkov, PhDb, Daniel Edmundowicz, MDa, Cheryl Rickens, BSNa, Gerald Pohost, MDc, Steven Buchthal, PhDc, Carl J. Pepine, MDd, George Sopko, MDe, Robert C. Sembrat, BSf, Carolyn Cidis Meltzer, MDf, Steven E. Reis, MDa
From the aCardiovascular Institute, University of Pittsburgh, Pittsburgh, Pa, bDepartment of Family and Preventive Medicine, School of Medicine, University of Utah, Salt Lake City, Utah, cDivision of Cardiology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala, dDivision of Cardiology, Department of Medicine, University of Florida, Gainesville, Fla, eDivision of Heart and Vascular Diseases, National Heart, Lung and Blood Institutes, Bethesda, Md, and the fDepartment of Radiology, University of Pittsburgh, Pittsburgh, Pa. 

Abstract

Background Women with chest pain in the absence of obstructive coronary artery disease (CAD) frequently have coronary microvascular dysfunction and inducible myocardial ischemia. Microvascular dysfunction is commonly diagnosed by demonstrating abnormal flow reserve in a single coronary artery during angiography. Therefore, diagnostic accuracy is dependent on homogeneity of microvascular dysfunction in the myocardium. Methods In the Women's Ischemia Syndrome Evaluation (WISE), 34 women with chest pain and no significant CAD and 9 female control subjects underwent 13N-NH3 positron emission tomography to measure adenosine-induced changes in myocardial perfusion (ie, coronary flow reserve [CFR]). Flow reserve was correlated among the left anterior descending (LAD), circumflex (LCx), and right (RCA) coronary artery distributions. Results The mean CFR in the LAD, LCx, and RCA was 2.85 ± 1.35, 2.58 ± 0.94, and 3.24 ± 1.42, respectively. Concordance in the classification of microvascular function as normal (CFR ≥2.5) versus abnormal was present in the LAD and RCA, LAD and LCx, and RCA and LCx distributions in only 71.8%, 66.7%, and 61.6% of patients, respectively. There was a modest degree of correlation of CFR between the LAD and RCA (r = 0.79, P < .001), LAD and LCx (r = 0.61, P < .001), and LCx and RCA (r = 0.57, P < .001). Comparison of CFR in the 3 coronary arteries simultaneously in all patients demonstrated that the LCx had values that were significantly lower than the RCA and LAD distributions. Conclusion Substantial discordance of classification of microvascular function among coronary artery distributions in women with chest pain and no CAD suggests that microvascular dysfunction is distributed heterogeneously in the myocardium. Assessment of CFR in a single coronary artery during cardiac catheterization may not provide an accurate assessment of the coronary microcirculation in women with chest pain not attributable to CAD. (Am Heart J 2003;145:628-35.)

Il testo completo di questo articolo è disponibile in PDF.

 Supported by the National Heart, Lung and Blood Institute contracts N01-HV-68161, N01-HV-68162, NO1-HV-68163, NO1-HV-68164 and grants from the Gustavis and Louis Pfeiffer Research Foundation; The Women's Guild, Cedars-Sinai Medical Center; Ladies Hospital Aid Society of Western Pennsylvania, University of Pittsburgh; and qmed, Inc.


© 2003  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 145 - N° 4

P. 628-635 - Aprile 2003 Ritorno al numero
Articolo precedente Articolo precedente
  • Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study
  • Gad Cotter, Christopher P. Cannon, Carolyn H. McCabe, Yoav Michowitz, Edo Kaluski, Andrew Charlesworth, Olga Milo, Jane Bentley, Alex Blatt, Rikardo Krakover, Reuven Zimlichman, Leonardo Reisin, Alon Marmor, Basil Lewis, Zvi Vered, Avi Caspi, Eugene Braunwald, OPUS-TIMI 16 Investigators
| Articolo seguente Articolo seguente
  • Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: The Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy
  • Victor L. Serebruany, Alex I. Malinin, Kevin P. Callahan, Azan Binbrek, Frans Van de Werf, John H. Alexander, Christopher B. Granger, Paul A. Gurbel

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.